Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Glow Lifetech Corp
(CSE:
GLOW
)
0.1000
+0.0550 (+122.22%)
Official Closing Price
Updated: 3:49 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
366,700
Open
0.0500
Bid (Size)
0.0500 (25,000)
Ask (Size)
0.1000 (20,000)
Prev. Close
0.0450
Today's Range
0.0500 - 0.1400
52wk Range
0.0200 - 0.1000
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Glow LifeTech Secures Canadian Processing Facility, Begins Build-out to Produce Next-Generation Cannabis Ingredients
May 28, 2021
Toronto, Ontario--(Newsfile Corp. - May 28, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a...
Via
Newsfile
Topics
Cannabis
Exposures
COVID-19
Cannabis
Glow LifeTech Reports on Additional Research Results on ArtemiC and Positive Implications for COVID-19 Variants
May 11, 2021
Toronto, Ontario--(Newsfile Corp. - May 11, 2021) - Glow LifeTech Corp. (CSE: GLOW) (FSE: 9DO) ("Glow" or the "Company"), a...
Via
Newsfile
Exposures
COVID-19
Performance
YTD
+185.71%
+185.71%
1 Month
+233.33%
+233.33%
3 Month
+233.33%
+233.33%
6 Month
+233.33%
+233.33%
1 Year
+42.86%
+42.86%
More News
Read More
Glow LifeTech Announces Successful First Commercial Production of ArtemiC(TM) for Global Distributor and a Second Production Scaled to Meet Growing Global Demand
May 04, 2021
Via
Newsfile
Exposures
COVID-19
Glow LifeTech Submits Application to Health Canada for Natural Health Product Following Successful COVID-19 Phase II Clinical Trial
April 27, 2021
Via
Newsfile
Exposures
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.